Turning TB Proficiency Testing Results Into Better Laboratory Practice
Proficiency testing (PT) gives tuberculosis laboratories an external measure of technical performance. By examining how accurately a laboratory detects, identifies, or reports TB-related results, supervisors can compare routine work with an accepted reference and identify risks that internal quality control may miss.
A PT result should never be treated as a simple pass or fail. An unsuccessful score may reflect a technical mistake, unclear procedures, a transcription problem, unsuitable equipment, weak supervision, or a specimen-handling failure. The value lies in understanding the cause and applying a correction that prevents the same issue from recurring.
Laboratories can use the GLI Quality Tool’s quality management approach to connect PT review with the Quality Systems Essentials. This creates a structured way to assess TB lab proficiency testing results and implement improvements while considering personnel, equipment, documents, assessment, safety, and continual improvement.
Establish A Clear Review Process
Before reviewing individual results, the laboratory should define who receives PT materials, who performs testing, who verifies findings, and who authorizes the final report. The procedure should specify timelines, confidentiality requirements, storage conditions, testing methods, and the records that must be retained. A documented process reduces confusion and protects the independence of the exercise.
PT samples should be handled as closely as possible to routine specimens. Staff should use the same equipment, reagents, worksheets, reporting system, and review steps used in daily work. Special treatment can create an unrealistic picture of laboratory capability and hide weaknesses that affect patient testing.
The laboratory manager should also ensure that staff understand the purpose of PT. It is an assessment of the testing system, not a disciplinary exercise. When personnel can report mistakes without fear, the laboratory is more likely to identify the real causes of an unsatisfactory outcome and correct them effectively.
Examine The Result Beyond The Score
Start by comparing the laboratory’s reported result with the provider’s assigned value. Review each sample separately and record whether the problem involved a false-positive result, a false-negative result, an incorrect identification, an inaccurate drug-resistance interpretation, a delayed submission, or a reporting error. The pattern is often more informative than the overall percentage.
Next, examine the technical records. Check the date and time of testing, staff member involved, specimen condition, reagent lot numbers, equipment status, control results, worksheets, instrument printouts, and final report. If the result was produced through microscopy, review the smear quality, staining, reading area, and number of fields examined. A structured double-checking guide can help laboratories reduce interpretation errors in smear microscopy.
The review should distinguish between analytical and administrative failures. A correct laboratory finding that was entered incorrectly is different from a technically incorrect result. Both require action, but the controls will differ. Data entry verification, clearer forms, or a second report review may resolve an administrative issue, while an analytical error may require retraining, method evaluation, or equipment maintenance.
Investigate Root Causes Systematically
A corrective action should be based on evidence rather than assumptions. Use a root-cause analysis method such as the five whys, a fishbone diagram, or a simple process map. Trace the complete pathway from receipt of the PT material to result submission. Identify where the process departed from the approved procedure.
Common contributing factors include inadequate training, unclear standard operating procedures, expired or poorly stored reagents, unsuitable control material, microscope problems, power interruptions, workload pressure, or insufficient time for result verification. In molecular testing, investigate invalid runs, contamination controls, cartridge handling, software settings, and interpretation of instrument flags. In culture and drug-susceptibility testing, review biosafety, incubation conditions, contamination, identification, and reading criteria.
Human error should be considered carefully. Describing a mistake as “operator error” does not explain why it happened. Ask whether the procedure was accessible, whether the person had been trained and assessed, whether the workspace supported accurate work, and whether another staff member would likely have made the same mistake. This approach directs improvement toward the system rather than blame.
| PT finding | Possible contributing cause | Immediate correction | Evidence of effectiveness |
|---|---|---|---|
| False-negative smear result | Poor smear preparation, staining defect, or limited reading | Review slides, repeat competency assessment, verify staining procedure | Improved blinded slide readings and acceptable controls |
| False-positive molecular result | Contamination or workflow crossover | Decontaminate work areas, review unidirectional workflow, repeat controls | Clean negative controls and stable run performance |
| Incorrect resistance interpretation | Misread algorithm or outdated reference document | Update SOP, conduct case-based training, verify calculations | Correct interpretation in competency samples |
| Delayed submission | Weak tracking or unclear responsibility | Add a PT calendar, assign an owner, set reminders | Results submitted within the provider’s deadline |
| Correct test, incorrect report | Transcription or verification failure | Introduce independent result review | Agreement between worksheets and submitted reports |
Convert Findings Into Corrective Action
Each identified problem should lead to a written corrective action plan. The plan should state the finding, likely root cause, action required, responsible person, deadline, resources, and method for checking completion. Actions should be specific enough that another supervisor can determine whether they were actually completed.
Immediate containment may be necessary when PT results suggest a risk to patient testing. The laboratory may need to review recent patient results, suspend a method temporarily, check affected reagent lots, repeat quality control, or refer testing to another qualified site. The decision should be documented, including the period reviewed and the reason for the chosen response.
Corrective action addresses an existing problem; preventive action reduces the chance of a similar problem elsewhere. For example, retraining one staff member may correct an individual gap, while revising the competency assessment process can prevent unrecognized weaknesses across the team. Updating a document, changing stock control, or improving result authorization may have a broader effect than repeating a single training session.
Verify That Improvements Work
Completion of an action is not proof that the problem has been solved. The laboratory needs an effectiveness check linked to the original risk. This may include repeat testing, a blinded panel, direct observation, review of internal quality control, competency reassessment, monitoring of rejected specimens, or an audit of reports.
Set a realistic review date. Some actions can be checked within days, while others require several weeks of routine data. If the laboratory introduces a new verification step, monitor whether staff use it consistently and whether it catches errors. If a reagent storage problem was corrected, review temperature records and related control results over time.
Trends should be reviewed during quality meetings. Repeated errors in one method, shift, staff group, or stage of the workflow may indicate a broader weakness. A single satisfactory PT round does not automatically demonstrate sustained competence, just as one poor result should not be interpreted without context. Combining PT performance with internal quality control, audits, turnaround time, and incident reports provides a stronger view of laboratory quality.
Preparation for external review can also expose gaps in PT follow-up. Laboratories may find it useful to review WHO SLMTA assessment preparation materials when organizing evidence of corrective actions, management review, and continual improvement.
Integrate PT Into The Quality System
PT records should be controlled documents within the laboratory quality management system. Keep the provider’s instructions, submitted results, score report, investigation, corrective action plan, effectiveness check, and management review together or cross-referenced in a retrievable file. Protect confidential information and limit access to authorized personnel.
The results should also be linked to relevant Quality Systems Essentials. A failed microscopy exercise may involve personnel competency, equipment, process control, documents, and assessment. A specimen transport problem may involve purchasing and inventory, customer service, facilities and safety, and occurrence management. This cross-reference helps managers avoid treating each PT event as an isolated incident.
Safety-related findings deserve particular attention. If a PT event reveals unsafe specimen handling, splash exposure, or poor spill response, update procedures and practice the response with staff. A clear specimen spillage protocol supports consistent action during an incident and can be incorporated into staff orientation and refresher training.
Prioritize Actions For Lasting Improvement
When resources are limited, laboratories should rank actions by risk to patient results, likelihood of recurrence, number of tests affected, and feasibility. A small change that strengthens result verification may prevent more harm than a broad training activity with no follow-up. The priority should be reliable testing and reporting, supported by practical controls that staff can maintain.
Use the following actions to keep PT review focused and sustainable:
- Assign one person to coordinate every PT cycle from receipt through effectiveness review.
- Review raw records, controls, equipment status, and staff competency rather than relying on the score alone.
- Record root causes and corrective actions in a format that includes owners, deadlines, and evidence requirements.
- Share lessons with the full testing team while protecting individual confidentiality.
- Discuss PT trends during management review and use them to update procedures, training, and risk controls.
A mature laboratory treats proficiency testing as a recurring source of operational intelligence. Each result can reveal where a process is dependable, where variation is emerging, and where a modest investment could strengthen patient care. The GLI Quality Tool provides a practical framework for documenting these lessons and connecting them to an organized improvement cycle.
Begin with the most recent PT report, assemble the related testing records, and hold a structured review with the staff involved. Document the cause, act on the highest-risk weakness, and schedule an effectiveness check so that improvement becomes measurable rather than assumed.